These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2070143

  • 21. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL, Avalos BR, Belt P, Taylor CA, Ezzone SA, Scholl MD, Fisher J, Young D, Copelan EA.
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [Abstract] [Full Text] [Related]

  • 22. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 23. Adenovirus infection after pediatric bone marrow transplantation.
    Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, Patrick CC.
    Bone Marrow Transplant; 1999 Feb; 23(3):277-82. PubMed ID: 10084260
    [Abstract] [Full Text] [Related]

  • 24. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
    Rubin CM, Mick R, Johnson FL.
    Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
    [Abstract] [Full Text] [Related]

  • 25. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine.
    Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C, van Rhee F, Plante M, Phang S, Barrett AJ.
    Bone Marrow Transplant; 1998 Nov; 22(9):889-93. PubMed ID: 9827817
    [Abstract] [Full Text] [Related]

  • 26. [Prevention of hemorrhagic cystitis due to cyclophosphamide for conditioning of bone marrow transplantation].
    Mori T, Harada M, Yoshida T, Ohotake S, Shiobara S, Matsue K, Odaka K, Kondo K, Nakao S, Ueda M.
    Rinsho Ketsueki; 1984 Apr; 25(4):528-34. PubMed ID: 6381790
    [No Abstract] [Full Text] [Related]

  • 27. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF, Maziarz R, Stiff P, Jansen J, Liesveld J, Andrews F, Schuster M, Wolff S, Litzow M, Karanes C, Dahlberg S, Kirkhart B, Bianco JA, Singer JW.
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients.
    Ballen KK, Becker P, Levebvre K, Emmons R, Lee K, Levy W, Stewart FM, Quesenberry P, Lowry P.
    Oncology; 1999 Nov; 57(4):287-92. PubMed ID: 10575313
    [Abstract] [Full Text] [Related]

  • 31. [The prevention of hemorrhagic cystitis during the performance of bone marrow and peripheral blood stem cell transplantation in the hematologic cancer clinic].
    Uss AL, Milanovich NF, Snegir' VM, Zmachinskiĭ VA, Skriagin AE.
    Ter Arkh; 1996 Nov; 68(10):49-52. PubMed ID: 9026944
    [Abstract] [Full Text] [Related]

  • 32. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [Abstract] [Full Text] [Related]

  • 33. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
    Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL.
    J Clin Oncol; 1991 Nov; 9(11):2016-20. PubMed ID: 1941060
    [Abstract] [Full Text] [Related]

  • 34. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.
    Tsuboi K, Kishi K, Ohmachi K, Yasuda Y, Shimizu T, Inoue H, Matsumoto M, Hattori K, Yoshiba F, Watanabe S, Ogawa Y, Kawada H, Yabe H, Yabe M, Kato S, Hotta T.
    Bone Marrow Transplant; 2003 Nov; 32(9):903-7. PubMed ID: 14561991
    [Abstract] [Full Text] [Related]

  • 35. Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants.
    Peinemann F, de Villiers EM, Dörries K, Adams O, Vögeli TA, Burdach S.
    Eur J Pediatr; 2000 Mar; 159(3):182-8. PubMed ID: 10664232
    [Abstract] [Full Text] [Related]

  • 36. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 37. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant.
    Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortés E, Ayala-Sanchez M, García-Ruiz Esparza MA, Rosas-Cabral A, Gonzalez-Llaven J.
    Bone Marrow Transplant; 1999 Dec; 24(12):1307-10. PubMed ID: 10627639
    [Abstract] [Full Text] [Related]

  • 38. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
    Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ.
    Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
    [Abstract] [Full Text] [Related]

  • 39. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration.
    Trotman J, Nivison-Smith I, Dodds A.
    Bone Marrow Transplant; 1999 Apr; 23(8):797-801. PubMed ID: 10231142
    [Abstract] [Full Text] [Related]

  • 40. Preventive measures for cyclophosphamide-related hemorrhagic cystitis in blood and bone marrow transplantation: an Italian multicenter retrospective study.
    Gonella S, di Pasquale T, Palese A.
    Clin J Oncol Nurs; 2015 Feb; 19(1):E8-E14. PubMed ID: 25689665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.